Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2015 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Jornal Brasileiro de Nefrologia |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002015000200198 |
Resumo: | Abstract Introduction/objective: We evaluated the predictability of early changes in serum albumin (sAlb) on the two-year mortality of incident hemodialysis patients. Methods: Observational, longitudinal retrospective study using the database of Fresenius Medical Care of Latin America. Adult patients starting dialysis from January/2000 to June/2004, from 25 centers were included. Changes in sAlb during the first 3 months on hemodialysis were used as the main predictor. The outcome was death from any cause. Results: 1,679 incident patients were included. They were 52 ± 15 years old, 58.7% male and 21.5% diabetic, with a median sAlb of 38 g/L (bromocresol green). 923 patients had sAlb < 38 g/L (Low sAlb Group) and 756 ones had sAlb > 38.0 g/L (Adequate sAlb Group). The mortality was significantly higher in Low sAlb Group (17% vs. 11%, p < 0.001). Early changes in sAlb significantly affected two-year mortality. Factoring the Kaplan Meier curve of Low sAlb Group by the presence of an increase in sAlb uncovered of a statistically significant difference in mortality favoring the ones whose sAlb went up (19% vs. 15%, p = 0.043). Differently, patients from Adequate sAlb Group with a decrease in their sAlb had a statistically higher mortality rate (13% vs. 8%, p = 0.029). Conclusions: Early sAlb changes showed a significant predictive power on mortality at 2 years in incident hemodialysis patients. Those with low initial sAlb may have a better prognosis if their sAlb rises. In contrast, patients with satisfactory initial levels can have a worsening of their prognosis in the case of an early reduction in sAlb. |
id |
SBN-1_1b1a848d9cf064e9b67b494101877c24 |
---|---|
oai_identifier_str |
oai:scielo:S0101-28002015000200198 |
network_acronym_str |
SBN-1 |
network_name_str |
Jornal Brasileiro de Nefrologia |
repository_id_str |
|
spelling |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patientskidney failure, chronicmortalityrenal dialysisserum albuminAbstract Introduction/objective: We evaluated the predictability of early changes in serum albumin (sAlb) on the two-year mortality of incident hemodialysis patients. Methods: Observational, longitudinal retrospective study using the database of Fresenius Medical Care of Latin America. Adult patients starting dialysis from January/2000 to June/2004, from 25 centers were included. Changes in sAlb during the first 3 months on hemodialysis were used as the main predictor. The outcome was death from any cause. Results: 1,679 incident patients were included. They were 52 ± 15 years old, 58.7% male and 21.5% diabetic, with a median sAlb of 38 g/L (bromocresol green). 923 patients had sAlb < 38 g/L (Low sAlb Group) and 756 ones had sAlb > 38.0 g/L (Adequate sAlb Group). The mortality was significantly higher in Low sAlb Group (17% vs. 11%, p < 0.001). Early changes in sAlb significantly affected two-year mortality. Factoring the Kaplan Meier curve of Low sAlb Group by the presence of an increase in sAlb uncovered of a statistically significant difference in mortality favoring the ones whose sAlb went up (19% vs. 15%, p = 0.043). Differently, patients from Adequate sAlb Group with a decrease in their sAlb had a statistically higher mortality rate (13% vs. 8%, p = 0.029). Conclusions: Early sAlb changes showed a significant predictive power on mortality at 2 years in incident hemodialysis patients. Those with low initial sAlb may have a better prognosis if their sAlb rises. In contrast, patients with satisfactory initial levels can have a worsening of their prognosis in the case of an early reduction in sAlb.Sociedade Brasileira de Nefrologia2015-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002015000200198Brazilian Journal of Nephrology v.37 n.2 2015reponame:Jornal Brasileiro de Nefrologiainstname:Sociedade Brasileira de Nefrologia (SBN)instacron:SBN10.5935/0101-2800.20150032info:eu-repo/semantics/openAccessPereira,Giselly Rosa ModestoStrogoff-de-Matos,Jorge PauloRuzany,FredericoSantos,Sergio Fernando Ferreira dosD'Almeida Filho,EufrônioVasconcelos,Marcos Sandro Fernandes deBarra,Ana BeatrizLugon,Jocemir Ronaldoeng2016-12-19T00:00:00Zoai:scielo:S0101-28002015000200198Revistahttp://www.bjn.org.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||jbn@sbn.org.br2175-82390101-2800opendoar:2016-12-19T00:00Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN)false |
dc.title.none.fl_str_mv |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
title |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
spellingShingle |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients Pereira,Giselly Rosa Modesto kidney failure, chronic mortality renal dialysis serum albumin |
title_short |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
title_full |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
title_fullStr |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
title_full_unstemmed |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
title_sort |
Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients |
author |
Pereira,Giselly Rosa Modesto |
author_facet |
Pereira,Giselly Rosa Modesto Strogoff-de-Matos,Jorge Paulo Ruzany,Frederico Santos,Sergio Fernando Ferreira dos D'Almeida Filho,Eufrônio Vasconcelos,Marcos Sandro Fernandes de Barra,Ana Beatriz Lugon,Jocemir Ronaldo |
author_role |
author |
author2 |
Strogoff-de-Matos,Jorge Paulo Ruzany,Frederico Santos,Sergio Fernando Ferreira dos D'Almeida Filho,Eufrônio Vasconcelos,Marcos Sandro Fernandes de Barra,Ana Beatriz Lugon,Jocemir Ronaldo |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Pereira,Giselly Rosa Modesto Strogoff-de-Matos,Jorge Paulo Ruzany,Frederico Santos,Sergio Fernando Ferreira dos D'Almeida Filho,Eufrônio Vasconcelos,Marcos Sandro Fernandes de Barra,Ana Beatriz Lugon,Jocemir Ronaldo |
dc.subject.por.fl_str_mv |
kidney failure, chronic mortality renal dialysis serum albumin |
topic |
kidney failure, chronic mortality renal dialysis serum albumin |
description |
Abstract Introduction/objective: We evaluated the predictability of early changes in serum albumin (sAlb) on the two-year mortality of incident hemodialysis patients. Methods: Observational, longitudinal retrospective study using the database of Fresenius Medical Care of Latin America. Adult patients starting dialysis from January/2000 to June/2004, from 25 centers were included. Changes in sAlb during the first 3 months on hemodialysis were used as the main predictor. The outcome was death from any cause. Results: 1,679 incident patients were included. They were 52 ± 15 years old, 58.7% male and 21.5% diabetic, with a median sAlb of 38 g/L (bromocresol green). 923 patients had sAlb < 38 g/L (Low sAlb Group) and 756 ones had sAlb > 38.0 g/L (Adequate sAlb Group). The mortality was significantly higher in Low sAlb Group (17% vs. 11%, p < 0.001). Early changes in sAlb significantly affected two-year mortality. Factoring the Kaplan Meier curve of Low sAlb Group by the presence of an increase in sAlb uncovered of a statistically significant difference in mortality favoring the ones whose sAlb went up (19% vs. 15%, p = 0.043). Differently, patients from Adequate sAlb Group with a decrease in their sAlb had a statistically higher mortality rate (13% vs. 8%, p = 0.029). Conclusions: Early sAlb changes showed a significant predictive power on mortality at 2 years in incident hemodialysis patients. Those with low initial sAlb may have a better prognosis if their sAlb rises. In contrast, patients with satisfactory initial levels can have a worsening of their prognosis in the case of an early reduction in sAlb. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002015000200198 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002015000200198 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/0101-2800.20150032 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Nefrologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Nephrology v.37 n.2 2015 reponame:Jornal Brasileiro de Nefrologia instname:Sociedade Brasileira de Nefrologia (SBN) instacron:SBN |
instname_str |
Sociedade Brasileira de Nefrologia (SBN) |
instacron_str |
SBN |
institution |
SBN |
reponame_str |
Jornal Brasileiro de Nefrologia |
collection |
Jornal Brasileiro de Nefrologia |
repository.name.fl_str_mv |
Jornal Brasileiro de Nefrologia - Sociedade Brasileira de Nefrologia (SBN) |
repository.mail.fl_str_mv |
||jbn@sbn.org.br |
_version_ |
1752122063784509440 |